Europe, Middle East & Africa
Innovation meets cardiovascular trial expertise.
心血管临床试验，无论其大小如何，都需要专门的，经验丰富的心血管CRO，以帮助您浏览成功的道路。
With unmatched cardiovascular trial experience and new approaches fueled by data and analytics, IQVIA brings agility and speed to trials large and small.
IQVIA's Experience
100%
of the top 20 cardiovascular drugs in 2019 were developed with help from IQVIA
New options for your cardiovascular trials
- Data and analytics foradaptive and novel trial approaches
- Innovative patient-centered trials usingvirtual and hybrid models
- 变革性技术必威官方在线identify the “right” sites and accelerate enrollment
- Proven track record and global leadership in患者保留和preventing LTFU
- Industry leading AI/ML driven technologies forRisk Based Monitoring
心血管research powered by the IQVIA CORE™
- Reduce patient burden withVirtual and Hybrid trial solutions
- Model and predict event rateswith the world’s largest healthcare data source
- 优化研究方案by refining eligibility criteria and schedule of assessments
- 创造Direct-to-patient multi-channel recruitment campaignsfor rare and common disease populations
- Enable以患者为中心的招聘和tailored site strategiesthrough new technology solutions
- 与wearables and connected devices
Solution
Virtual Approaches for Cardiovascular Trials
IQVIA将心血管患者的需求放在临床研究的中心，并采用正确的技术来提高您的研究表现。
Challenges of cardiovascular development
- 减少心血管试验的时间和成本的压力
- Need for fast site activation and recruitment of extremely large patient populations globally
- Retention of patients to prevent lost to follow-up (LTFU) over the length of the study
- Analysis of vast amounts of data quickly to detect safety signals and endpoint information
Our latest thinking on Cv
Case Study
全球心血管医疗设备救援试验
Institute Report
The Changing Landscape of Research and Development
相关解决方案
Clinical Trials
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Emerging Biopharma
灵活的解决方案。响应迅速的团队。数据驱动的见解。betway必威怎么提款
Cell & Gene Therapy Center
Access new resources for advanced therapy development, from candidate identification through market authorization.